Home › Trial NCT00078520
Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells
- Trial IDNCT00078520
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorBaylor College of Medicine
- Enrollment9
- Start date2003-01
- ConditionsLeukemia · Leukemia, B-Cell, Chronic
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.